Biochemical and Biological Differences Between E7 Oncoproteins of the High- and Low-risk Human Papillomavirus Types Are Determined by Amino-terminal Sequences

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1991 Jul 1

PMID 1645802

Citations 41

Authors

K Munger

C L Yee

W C Phelps

J A Pietenpol

H L Moses

P M Howley

Affiliations

Soon will be listed here.

Abstract

Differences in the biological characteristics of the high-risk human papillomavirus type 16 (HPV-16) and the low-risk HPV-6 E7 proteins were analyzed and shown to correlate with certain biochemical properties. To ascertain which region of E7 conferred these properties, chimeric E7 genes were constructed by the exchange of the amino and carboxyl coding halves of the HPV-6 and HPV-16 E7 genes. The amino-terminal half of E7 determined the affinity for binding to the retinoblastoma protein pRB, the transformation properties, and the ability to abrogate transforming growth factor beta-mediated repression of the c-myc promoter. This region of E7 is therefore responsible for the biological and biochemical differences between the E7 proteins of the low-risk and the high-risk HPVs and consequently is one of the critical determinants distinguishing these two groups of viruses. Transcriptional transactivation of the adenovirus E2 promoter, in contrast, was a property shared by E7 proteins of both low-risk and high-risk HPVs.

Citing Articles

Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients.

Paradowska E, Jablonska A, Studzinska M, Wilczynski M, Wilczynski J Sci Rep. 2019; 9(1):19935.

PMID: 31882737 PMC: 6934444. DOI: 10.1038/s41598-019-56448-1.

Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.

Cerasuolo A, Annunziata C, Tortora M, Starita N, Stellato G, Greggi S Oncotarget. 2017; 8(21):34070-34081.

PMID: 28423662 PMC: 5470952. DOI: 10.18632/oncotarget.15977.

Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation.

Kumari A, Iwasaki T, Pyndiah S, Cassimere E, Palani C, Sakamuro D Cell Death Differ. 2014; 22(2):311-22.

PMID: 25257171 PMC: 4291492. DOI: 10.1038/cdd.2014.146.

The papillomavirus E7 proteins.

Roman A, Munger K Virology. 2013; 445(1-2):138-68.

PMID: 23731972 PMC: 3783579. DOI: 10.1016/j.virol.2013.04.013.

Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Klingelhutz A, Roman A Virology. 2012; 424(2):77-98.

PMID: 22284986 PMC: 3703738. DOI: 10.1016/j.virol.2011.12.018.

References

Bedell M, Jones K, Grossman S, Laimins L . Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. J Virol. 1989; 63(3):1247-55. PMC: 247821. DOI: 10.1128/JVI.63.3.1247-1255.1989. View

Tanaka A, Noda T, Yajima H, Hatanaka M, Ito Y . Identification of a transforming gene of human papillomavirus type 16. J Virol. 1989; 63(3):1465-9. PMC: 247853. DOI: 10.1128/JVI.63.3.1465-1469.1989. View

Whyte P, Williamson N, Harlow E . Cellular targets for transformation by the adenovirus E1A proteins. Cell. 1989; 56(1):67-75. DOI: 10.1016/0092-8674(89)90984-7. View

Ewen M, Ludlow J, Marsilio E, DeCaprio J, Millikan R, Cheng S . An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell. 1989; 58(2):257-67. DOI: 10.1016/0092-8674(89)90840-4. View

Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G . Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet. 1990; 335(8699):1171-4. DOI: 10.1016/0140-6736(90)92693-c. View

Werness B, Levine A, Howley P . Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990; 248(4951):76-9. DOI: 10.1126/science.2157286. View

Storey A, Osborn K, Crawford L . Co-transformation by human papillomavirus types 6 and 11. J Gen Virol. 1990; 71 ( Pt 1):165-71. DOI: 10.1099/0022-1317-71-1-165. View

Barbosa M, Edmonds C, Fisher C, Schiller J, Lowy D, Vousden K . The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J. 1990; 9(1):153-60. PMC: 551641. DOI: 10.1002/j.1460-2075.1990.tb08091.x. View

Watanabe S, Kanda T, Sato H, Furuno A, Yoshiike K . Mutational analysis of human papillomavirus type 16 E7 functions. J Virol. 1990; 64(1):207-14. PMC: 249086. DOI: 10.1128/JVI.64.1.207-214.1990. View

10.

Gage J, Meyers C, WETTSTEIN F . The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J Virol. 1990; 64(2):723-30. PMC: 249166. DOI: 10.1128/JVI.64.2.723-730.1990. View

11.

Hudson J, Bedell M, McCance D, Laiminis L . Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol. 1990; 64(2):519-26. PMC: 249139. DOI: 10.1128/JVI.64.2.519-526.1990. View

12.

Pietenpol J, Stein R, Moran E, Yaciuk P, Schlegel R, Lyons R . TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell. 1990; 61(5):777-85. DOI: 10.1016/0092-8674(90)90188-k. View

13.

Durst M, Gissmann L, Ikenberg H, zur Hausen H . A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983; 80(12):3812-5. PMC: 394142. DOI: 10.1073/pnas.80.12.3812. View

14.

Firzlaff J, Galloway D, Eisenman R, Luscher B . The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II. New Biol. 1989; 1(1):44-53. View

15.

Scheffner M, Werness B, Huibregtse J, Levine A, Howley P . The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990; 63(6):1129-36. DOI: 10.1016/0092-8674(90)90409-8. View

16.

Barbosa M, Vass W, Lowy D, Schiller J . In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential. J Virol. 1991; 65(1):292-8. PMC: 240516. DOI: 10.1128/JVI.65.1.292-298.1991. View

17.

RAWLS J, Pusztai R, Green M . Chemical synthesis of human papillomavirus type 16 E7 oncoprotein: autonomous protein domains for induction of cellular DNA synthesis and for trans activation. J Virol. 1990; 64(12):6121-9. PMC: 248786. DOI: 10.1128/JVI.64.12.6121-6129.1990. View

18.

Barbosa M, Lowy D, Schiller J . Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. J Virol. 1989; 63(3):1404-7. PMC: 247840. DOI: 10.1128/JVI.63.3.1404-1407.1989. View

19.

Vousden K, DONIGER J, DIPAOLO J, Lowy D . The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Res. 1988; 3(2):167-75. View

20.

Phelps W, Yee C, Munger K, Howley P . The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell. 1988; 53(4):539-47. DOI: 10.1016/0092-8674(88)90570-3. View